Patents | Intellepedia

Happy Eid al-Adha – Biryani Patents

This post examines innovative biryani patents and Eid al-Adha culinary traditions, with a focus on food-related intellectual property. It also addresses Indian GI protection for iconic dishes like Hyderabadi Biryani.

Letter to the PM against Software patenting

A collective letter to the Prime Minister raises critical issues regarding the 2015 software patenting guidelines, citing potential harm to innovation and conflicts with Indian law. The post analyses stakeholder concerns and the legal implications for the Indian software industry.

Gilead, IPA, Natco & The Bells of Harmony

The post examines the collaboration between Gilead, IPA, and Natco Pharma regarding the sofosbuvir patent in India. It analyses how voluntary licensing and innovative policies are improving access to affordable medicines while balancing public health and patent rights.

Idols, Patents and Ganesha- Happy Vinayaka Chavithi!

The post explores how Ganesha idols intersect with patent law and eco-friendly innovations during Ganesh Chaturthi. It highlights inventive methods of idol making and their legal implications in India.

TiVo and Patent Infringement

TiVo has sued Samsung for allegedly infringing four of its multimedia technology patents, targeting both set-top boxes and mobile devices. This litigation highlights TiVo’s ongoing strategy to protect its intellectual property amid evolving market dynamics.

Ericsson has a (i)Ball at the Court

The Delhi High Court granted an interim injunction to Ericsson against iBall in a significant patent infringement dispute involving standard essential patents for mobile technologies. The court found in favour of Ericsson, stressing the importance of prompt patent rights enforcement in India.

Tequila’s Indian Cousin

An Indian food scientist has patented a process to produce tequila-like alcohol from Agave albomarginata, a plant native to the Rayalseema region. The innovation uses the plant’s high-starch pith, yielding a natural, cost-effective spirit called Naturohol.

Pfizer files for Patent on Known Substance

This post examines Pfizer’s patent application on a known substance and the Indian Patent Office’s refusal in light of Section 3d and the Novartis decision. It discusses whether unpublished patent applications can render a substance as “known” and critiques the merging of novelty and subject matter analysis.

Pfizer falls prey to Section 3(d)

This post analyses the Indian Patent Office’s rejection of Pfizer’s Tofacitinib patent under Section 3(d). The decision addresses issues of novelty, inventive step, and the requirement for evidence of enhanced efficacy in pharmaceutical patent applications.

Working of Patents – A Workable Proposition?

This article critically examines the working of patents in India, focusing on statutory requirements, compulsory licensing, and judicial interpretations. It discusses both commercial and non-commercial working, highlighting the practical complexities faced by patentees under the Indian Patents Act.